Please use this identifier to cite or link to this item:
Appears in Collections:Faculty of Health Sciences and Sport Systematic Reviews
Peer Review Status: Refereed
Title: Lipid-lowering for peripheral arterial disease of the lower limb
Other Titles: Lipid-lowering for lower limb atherosclerosis
Author(s): Aung, Phyu Phyu
Maxwell, Heather
Jepson, Ruth
Price, Jackie
Leng, Gillian C
Contact Email:
Citation: Aung PP, Maxwell H, Jepson R, Price J & Leng GC (2009) Lipid-lowering for peripheral arterial disease of the lower limb (Review) [Lipid-lowering for lower limb atherosclerosis]. Cochrane Database of Systematic Reviews, (1), Art. No.: CD000123.pub2.
Issue Date: 2009
Date Deposited: 21-Jan-2013
Publisher: Wiley-Blackwell for the Cochrane Collaboration
Abstract: Background: Lipid-lowering therapy is recommended for secondary prevention in people with coronary artery disease. It may also reduce cardiovascular events and/or local disease progression in people with lower limb peripheral arterial disease (PAD). Objectives: To assess the effects of lipid-lowering therapy on all-cause mortality, cardiovascular events and local disease progression in patients with PAD of the lower limb. Search methods: The authors searched The Cochrane Peripheral Vascular Diseases Group's Specialised Register (last searched February 2007) and the Cochrane Central Register of Controlled Trials (CENTRAL) (last searched Issue 2, 2007) for publications describing randomised controlled trials of lipid-lowering therapy in peripheral arterial disease of the lower limb. Selection criteria: Randomised controlled trials of lipid-lowering therapy in patients with PAD of the lower limb. Data collection and analysis: Three authors independently assessed trial quality and extracted data. Main results: Eighteen trials were included, involving a total of 10,049 participants. Trials differed considerably in their inclusion criteria, outcomes measured, and type of lipid-lowering therapy used. Only one trial (PQRST) reported a detrimental effect of active treatment on blood lipid/lipoprotein levels. The pooled results from all eligible trials indicated that lipid-lowering therapy had no statistically significant effect on overall mortality (Odds Ratio (OR) 0.86; 95% Confidence Interval (CI) 0.49 to 1.50) or on total cardiovascular events (OR 0.8; 95% CI 0.59 to 1.09). However, subgroup analysis which excluded PQRST showed that lipid-lowering therapy significantly reduced the risk of total cardiovascular events (OR 0.74; CI 0.55 to 0.98). This was primarily due to a positive effect on total coronary events (OR 0.76; 95% CI 0.67 to 0.87). Greatest evidence of effectiveness came from the use of simvastatin in people with a blood cholesterol ≥ 3.5 mmol/litre (HPS). Pooling of the results from several small trials on a range of different lipid-lowering agents indicated an improvement in total walking distance (Mean Difference (MD) 152 m; 95% CI 32.11 to 271.88) and pain-free walking distance (WMD 89.76 m; 95% CI 30.05 to 149.47) but no significant impact on ankle brachial index (WMD 0.04; 95% CI -0.01 to 0.09). Authors' conclusions: Lipid-lowering therapy is effective in reducing cardiovascular mortality and morbidity in people with PAD. It may also improve local symptoms. Until further evidence on the relative effectiveness of different lipid-lowering agents is available, use of a statin in people with PAD and a blood cholesterol level ≥ 3.5 mmol/litre is most indicated.
Article no.: CD000123.pub2
Type: Journal Article
Affiliation: University of Edinburgh
University of Edinburgh
Health Sciences Stirling
University of Edinburgh
London School of Hygiene and Tropical Medicine

Files in This Item:
File Description SizeFormat 
Aung et al_Cochrane_2009.pdfFulltext - Published Version621.87 kBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.